HOTH THERAPEUTICS INC (HOTH) Stock Income Statement
NASDAQ:HOTH - Nasdaq - US44148G2049 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.22M | 7.69M | 11.07M | 14.10M | 7.30M | |||
| Research and Development | 3.25M | 3.48M | 4.93M | 7.53M | 2.89M | |||
| Selling, General, and Administrative Expenses | 4.97M | 4.21M | 5.15M | 5.79M | 3.96M | |||
| Operating Income | -8.22M | -7.69M | -11.07M | -14.10M | -7.30M | |||
| Interest Income/Expense | 27.10K | -153.20K | -760.00K | N/A | 0.00 | |||
| Other Income/Expense | N/A | 0.00 | 450.00K | -210.00K | 100.00K | |||
| Income Before Taxes | -8.19M | -7.85M | -11.37M | -14.31M | -7.20M | |||
| Net Income | -8.19M | -7.85M | -11.37M | -14.31M | -7.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.28 | -2.30 | -9.47 | -16.07 | -14.69 | |||
| Non GAAP EPS | -1.33 | -2.37 | -9.91 | -16.50 | -14.50 | |||
| Statistics | ||||||||
All data in USD